Two-way communication between the metabolic and cell cycle machineries: the molecular basis

Cell Cycle

Volumn 14, Issue 13, 2015, Pages 2022-2032

  Kaplon, Joanna ^a   van Dam, Loes ^b   Peeper, Daniel ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cell cycle; Cyclin dependent kinases; Glycolysis; Metabolism; Nutrients; Proliferation

Indexed keywords

ACETYL COENZYME A; ADENYLATE KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; NICOTINAMIDE ADENINE DINUCLEOTIDE; PK ISOFORM M2 PROTEIN; PROTEIN P53; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG;

CELL COMMUNICATION; CELL CYCLE; CELL CYCLE REGULATION; CELL METABOLISM; GLYCOLYSIS; HUMAN; METABOLIC REGULATION; NEOPLASM; NONHUMAN; REVIEW; ANIMAL; CELL DIVISION; CELL SURVIVAL; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL COMMUNICATION; CELL CYCLE; CELL DIVISION; CELL SURVIVAL; HUMANS; METABOLIC NETWORKS AND PATHWAYS; SIGNAL TRANSDUCTION;

EID: 84943738406     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.1080/15384101.2015.1044172     Document Type: Review

References (149)

1. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324: 1029-33; PMID: 19460998; http://dx. doi. org/10. 1126/science. 1160809.
2. Cantor JR, Sabatini DM. Cancer cell metabolism: one hallmark, many faces. Cancer Discov 2012; 2: 881-98; PMID: 23009760; http://dx. doi. org/10. 1158/2159-8290. CD-12-0345.
3. Ward PS, Thompson CB. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell 2012; 21: 297-308; PMID: 22439925; http://dx. doi. org/10. 1016/j. ccr. 2012. 02. 014.
4. Hedeskov CJ. Early effects of phytohaemagglutinin on glucose metabolism of normal human lymphocytes. Biochem J 1968; 110: 373-80; PMID: 5726214.
5. Brand K. Glutamine and glucose metabolism during thymocyte proliferation. Pathways of glutamine and glutamate metabolism. Biochem J 1985; 228: 353-61; PMID: 2861809.
6. Wang T, Marquardt C, Foker J. Aerobic glycolysis during lymphocyte proliferation. Nature 1976 Jun 24; 261(5562): 702-5; http://dx. doi. org/10. 1038/261702a0.
7. Steck TL, Kaufman S, Bader JP. Glycolysis in chick embryo cell cultures transformed by Rous sarcoma virus. Cancer Res 1968; 28: 1611-9; PMID: 4299826.
8. Kondoh H, Lleonart ME, Nakashima Y, Yokode M, Tanaka M, Bernard D, Gil J, Beach D. A high glycolytic flux supports the proliferative potential of murine embryonic stem cells. Antioxid Redox Signal 2007; 9: 293-9; PMID: 17184172; http://dx. doi. org/10. 1089/ars. 2006. 1467.
9. Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. J Gen Physiol 1927; 8: 519-30; PMID: 19872213; http://dx. doi. org/10. 1085/jgp. 8. 6. 519.
10. Granot D, Snyder M. Glucose induces cAMP-independent growth-related changes in stationary-phase cells of Saccharomyces cerevisiae. Proc Natl Acad Sci USA 1991; 88: 5724-8; PMID: 1648229; http://dx. doi. org/10. 1073/pnas. 88. 13. 5724.
11. Chen Z, Odstrcil EA, Tu BP, McKnight SL. Restriction of DNA replication to the reductive phase of the metabolic cycle protects genome integrity. Science 2007; 316: 1916-9; PMID: 17600220; http://dx. doi. org/10. 1126/science. 1140958.
12. Hartwell LH, Culotti J, Pringle JR, Reid BJ. Genetic control of the cell division cycle in yeast. Science 1974; 183: 46-51; PMID: 4587263; http://dx. doi. org/10. 1126/science. 183. 4120. 46.
13. Jong AY, Kuo CL, Campbell JL. The CDC8 gene of yeast encodes thymidylate kinase. J Biol Chem 1984; 259: 11052-9; PMID: 6088527.
14. Maitra PK, Lobo Z. Pyruvate kinase mutants of Saccharomyces cerevisiae: biochemical and genetic characterisation. Mol Gen Genet 1977; 152: 193-200; PMID: 327275; http://dx. doi. org/10. 1007/BF00268817.
15. Game JC. Yeast cell-cycle mutant cdc21 is a temperature-sensitive thymidylate auxotroph. Mol Gen Genet 1976; 146: 313-5; PMID: 794696; http://dx. doi. org/10. 1007/BF00701257.
16. Dickinson JR, Williams AS. The cdc30 mutation in Saccharomyces cerevisiae results in a temperature-sensitive isoenzyme of phosphoglucose isomerase. J Gen Microbiol 1987; 133: 135-40; PMID: 3309140.
17. Wrobel C, Schmidt EV, Polymenis M. CDC64 encodes cytoplasmic alanyl-tRNA synthetase, Ala1p, of Saccharomyces cerevisiae. J Bacteriol 1999; 181: 7618-20; PMID: 10601222.
18. Cho RJ, Campbell MJ, Winzeler EA, Steinmetz L, Conway A, Wodicka L, Wolfsberg TG, Gabrielian AE, Landsman D, Lockhart DJ, et al. A genome-wide transcriptional analysis of the mitotic cell cycle. Mol Cell 1998; 2: 65-73; PMID: 9702192; http://dx. doi. org/10. 1016/S1097-2765(00)80114-8.
19. Spellman PT, Sherlock G, Zhang MQ, Iyer VR, Anders K, Eisen MB, Brown PO, Botstein D, Futcher B. Comprehensive identification of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hybridization. Mol Biol Cell 1998; 9: 3273-97; PMID: 9843569; http://dx. doi. org/10. 1091/mbc. 9. 12. 3273.
20. Lloyd AC. The regulation of cell size. Cell 2013; 154: 1194-205; PMID: 24034244; http://dx. doi. org/10. 1016/j. cell. 2013. 08. 053.
21. Boer VM, Crutchfield CA, Bradley PH, Botstein D, Rabinowitz JD. Growth-limiting intracellular metabolites in yeast growing under diverse nutrient limitations. Mol Biol Cell 2010; 21: 198-211; PMID: 19889834; http://dx. doi. org/10. 1091/mbc. E09-07-0597.
22. Conlon I, Raff M. Differences in the way a mammalian cell and yeast cells coordinate cell growth and cell-cycle progression. J Biol 2003; 2: 7; PMID: 12733998; http://dx. doi. org/10. 1186/1475-4924-2-7.
23. Rathmell JC, Vander Heiden MG, Harris MH, Frauwirth KA, Thompson CB. In the absence of extrinsic signals, nutrient utilization by lymphocytes is insufficient to maintain either cell size or viability. Mol Cell 2000; 6: 683-92; PMID: 11030347; http://dx. doi. org/10. 1016/S1097-2765(00)00066-6.
24. Langan TJ, Chou RC. Synchronization of mammalian cell cultures by serum deprivation. Methods Mol Biol 2011; 761: 75-83; PMID: 21755442; http://dx. doi. org/10. 1007/978-1-61779-182-6_5.
25. Levine AJ, Puzio-Kuter AM. The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes. Science 2010; 330: 1340-4; PMID: 21127244; http://dx. doi. org/10. 1126/science. 1193494.
26. Jones RG, Thompson CB. Tumor suppressors and cell metabolism: a recipe for cancer growth. Genes Dev 2009; 23: 537-48; PMID: 19270154; http://dx. doi. org/10. 1101/gad. 1756509.
27. Tu BP, Mohler RE, Liu JC, Dombek KM, Young ET, Synovec RE, McKnight SL. Cyclic changes in metabolic state during the life of a yeast cell. Proc Natl Acad Sci USA 2007; 104: 16886-91; PMID: 17940006; http://dx. doi. org/10. 1073/pnas. 0708365104.
28. Benanti JA, Cheung SK, Brady MC, Toczyski DP. A proteomic screen reveals SCFGrr1 targets that regulate the glycolytic-gluconeogenic switch. Nat Cell Biol 2007; 9: 1184-91; PMID: 17828247; http://dx. doi. org/10. 1038/ncb1639.
29. Herrero-Mendez A, Almeida A, Fernández E, Maestre C, Moncada S, Bolaños JP. The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1. Nat Cell Biol 2009; 11: 747-52; PMID: 19448625; http://dx. doi. org/10. 1038/ncb1881.
30. Hartwell LH, Weinert TA. Checkpoints: controls that ensure the order of cell cycle events. Science 1989; 246: 629-34; PMID: 2683079; http://dx. doi. org/10. 1126/science. 2683079.
31. Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 2009; 9: 153-66; PMID: 19238148; http://dx. doi. org/10. 1038/nrc2602.
32. Sherr CJ. G1 phase progression: cycling on cue. Cell 1994; 79: 551-5; PMID: 7954821; http://dx. doi. org/10. 1016/0092-8674(94)90540-1.
33. Lim S, Kaldis P. Cdks, cyclins and CKIs: roles beyond cell cycle regulation. Development 2013; 140: 3079-93; PMID: 23861057; http://dx. doi. org/10. 1242/dev. 091744.
34. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999; 13: 1501-12; PMID: 10385618; http://dx. doi. org/10. 1101/gad. 13. 12. 1501.
35. Kushner JA, Ciemerych MA, Sicinska E, Wartschow LM, Teta M, Long SY, Sicinski P, White MF. Cyclins D2 and D1 are essential for postnatal pancreatic b-cell growth. Mol Cell Biol 2005; 25: 3752-62; PMID: 15831479; http://dx. doi. org/10. 1128/MCB. 25. 9. 3752-3762. 2005.
36. Sarruf DA, Iankova I, Abella A, Assou S, Miard S, Fajas L. Cyclin D3 promotes adipogenesis through activation of peroxisome proliferator-activated receptor gamma. Mol Cell Biol 2005; 25: 9985-95; PMID: 16260612; http://dx. doi. org/10. 1128/MCB. 25. 22. 9985-9995. 2005.
37. Sakamaki T, Casimiro MC, Ju X, Quong AA, Katiyar S, Liu M, Jiao X, Li A, Zhang X, Lu Y, et al. Cyclin D1 determines mitochondrial function in vivo. Mol Cell Biol 2006; 26: 5449-69; PMID: 16809779; http://dx. doi. org/10. 1128/MCB. 02074-05.
38. Hanse EA, Mashek DG, Becker JR, Solmonson AD, Mullany LK, Mashek MT, Towle HC, Chau AT, Albrecht JH. Cyclin D1 inhibits hepatic lipogenesis via repression of carbohydrate response element binding protein and hepatocyte nuclear factor 4a. cc 2012; 11: 2681-90; http://dx. doi. org/10. 4161/cc. 21019.
39. Wang C, Li Z, Lu Y, Du R, Katiyar S, Yang J, Fu M, Leader JE, Quong A, Novikoff PM, et al. Cyclin D1 repression of nuclear respiratory factor 1 integrates nuclear DNA synthesis and mitochondrial function. Proc Natl Acad Sci USA 2006; 103: 11567-72; PMID: 16864783; http://dx. doi. org/10. 1073/pnas. 0603363103.
40. Tchakarska G, Roussel M, Troussard X, Sola B. Cyclin D1 inhibits mitochondrial activity in B cells. Cancer Res 2011; 71: 1690-9; PMID: 21343394; http://dx. doi. org/10. 1158/0008-5472. CAN-10-2564.
41. Bienvenu F, Jirawatnotai S, Elias JE, Meyer CA, Mizeracka K, Marson A, Frampton GM, Cole MF, Odom DT, Odajima J, et al. Transcriptional role of cyclin D1 in development revealed by a genetic-proteomic screen. Nature 2010; 463: 374-8; PMID: 20090754; http://dx. doi. org/10. 1038/nature08684.
42. Buchakjian MR, Kornbluth S. The engine driving the ship: metabolic steering of cell proliferation and death. Nat Rev Mol Cell Biol 2010 Oct; 11(10): 715-27; http://dx. doi. org/10. 1038/nrm2972.
43. Yang K, Hitomi M, Stacey DW. Variations in cyclin D1 levels through the cell cycle determine the proliferative fate of a cell. Cell Division 2006; 1: 32; PMID: 17176475; http://dx. doi. org/10. 1186/1747-1028-1-32.
44. Dimova DK, Dyson NJ. The E2F transcriptional network: old acquaintances with new faces. Oncogene 2005; 24: 2810-26; PMID: 15838517; http://dx. doi. org/10. 1038/sj. onc. 1208612.
45. Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat Rev Cancer 2009; 9: 785-97; PMID: 19851314; http://dx. doi. org/10. 1038/nrc2696.
46. Fajas L, Landsberg RL, Huss-Garcia Y, Sardet C, Lees JA, Auwerx J. E2Fs Regulate Adipocyte Differentiation. Dev Cell 2002; 3: 39-49; PMID: 12110166; http://dx. doi. org/10. 1016/S1534-5807(02)00190-9.
47. Abella A, Dubus P, Malumbres M, Rane SG, Kiyokawa H, Sicard A, Vignon F, Langin D, Barbacid M, Fajas L. Cdk4 promotes adipogenesis through PPARgamma activation. Cell Metab 2005; 2: 239-49; PMID: 16213226; http://dx. doi. org/10. 1016/j. cmet. 2005. 09. 003.
48. Fajas L, Egler V, Reiter R, Hansen J, Kristiansen K, Debril M, Miard S, Auwerx J. The Retinoblastoma-Histone Deacetylase 3 Complex Inhibits PPARg and Adipocyte Differentiation. Dev Cell 2002; 3: 903-10; PMID: 12479814; http://dx. doi. org/10. 1016/S1534-5807(02)00360-X.
49. Chen PL, Riley DJ, Chen Y, Lee WH. Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes Dev 1996; 10: 2794-804; PMID: 8946919; http://dx. doi. org/10. 1101/gad. 10. 21. 2794.
50. Fajas L, Annicotte J-S, Miard S, Sarruf D, Watanabe M, Auwerx J. Impaired pancreatic growth, b cell mass, and b cell function in E2F1 (¡/¡)mice. J Clin Invest 2004; 113: 1288-95; PMID: 15124020; http://dx. doi. org/10. 1172/JCI18555.
51. Annicotte J-S, Blanchet E, Chavey C, Iankova I, Costes S, Assou S, Teyssier J, Dalle S, Sardet C, Fajas L. The CDK4-pRB-E2F1 pathway controls insulin secretion. Nat Cell Biol 2009; 11: 1017-23; PMID: 19597485; http://dx. doi. org/10. 1038/ncb1915.
52. Roche TE, Hiromasa Y. Pyruvate dehydrogenase kinase regulatory mechanisms and inhibition in treating diabetes, heart ischemia, and cancer. Cell Mol Life Sci 2007; 64: 830-49; PMID: 17310282; http://dx. doi. org/10. 1007/s00018-007-6380-z.
53. Hsieh MCF, Das D, Sambandam N, Zhang MQ, Nahlé Z. Regulation of the PDK4 isozyme by the Rb-E2F1 complex. J Biol Chem 2008; 283: 27410-7; PMID: 18667418; http://dx. doi. org/10. 1074/jbc. M802418200.
54. Darville MI, Antoine IV, Mertens-Strijthagen JR, Dupriez VJ, Rousseau GG. An E2F-dependent late-serum-response promoter in a gene that controls glycolysis. Oncogene 1995; 11: 1509-17; PMID: 7478575.
55. Goto Y, Hayashi R, Kang D, Yoshida K. Acute loss of transcription factor E2F1 induces mitochondrial biogenesis in HeLa cells. J Cell Physiol 2006; 209: 923-34; PMID: 16972274; http://dx. doi. org/10. 1002/jcp. 20802.
56. Blanchet E, Annicotte J-S, Lagarrigue S, Aguilar V, Clapé C, Chavey C, Fritz V, Casas F, Apparailly F, Auwerx J, et al. E2F transcription factor-1 regulates oxidative metabolism. Nat Cell Biol 2011; 13: 1146-52; PMID: 21841792; http://dx. doi. org/10. 1038/ncb2309.
57. Naaz A, Holsberger DR, Iwamoto GA, Nelson A, Kiyokawa H, Cooke PS. Loss of cyclin-dependent kinase inhibitors produces adipocyte hyperplasia and obesity. FASEB J 2004; 18: 1925-7; PMID: 15469964.
58. Inoue N, Yahagi N, Yamamoto T, Ishikawa M, Watanabe K, Matsuzaka T, Nakagawa Y, Takeuchi Y, Kobayashi K, Takahashi A, et al. Cyclin-dependent kinase inhibitor, p21WAF1/CIP1, is involved in adipocyte differentiation and hypertrophy, linking to obesity, and insulin resistance. J Biol Chem 2008; 283: 21220-9; PMID: 18445590; http://dx. doi. org/10. 1074/jbc. M801824200.
59. Lin J, Della-Fera MA, Li C, Page K, Choi YH, Hartzell DL, Baile CA. P27 knockout mice: reduced myostatin in muscle and altered adipogenesis. Biochem Biophys Res Commun 2003; 300: 938-42; PMID: 12559964; http://dx. doi. org/10. 1016/S0006-291X(02)02949-2.
60. Uchida T, Nakamura T, Hashimoto N, Matsuda T, Kotani K, Sakaue H, Kido Y, Hayashi Y, Nakayama KI, White MF, et al. Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice. Nat Med 2005; 11: 175-82; PMID: 15685168; http://dx. doi. org/10. 1038/nm1187.
61. Pagano M. Cell cycle regulation by the ubiquitin pathway. FASEB J 1997; 11: 1067-75; PMID: 9367342.
62. Skaar JR, Pagano M. Cdh1: a master G0/G1 regulator. Nat Cell Biol 2008; 10: 755-7; PMID: 18591966; http://dx. doi. org/10. 1038/ncb0708-755.
63. Matyskiela ME, Rodrigo-Brenni MC, Morgan DO. Mechanisms of ubiquitin transfer by the anaphasepromoting complex. J Biol 2009; 8: 92; PMID: 19874575; http://dx. doi. org/10. 1186/jbiol184.
64. Skowyra D, Craig KL, Tyers M, Elledge SJ, Harper JW. F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex. Cell 1997; 91: 209-19; PMID: 9346238; http://dx. doi. org/10. 1016/S0092-8674(00)80403-1.
65. Skaar JR, Pagan JK, Pagano M. Mechanisms and function of substrate recruitment by F-box proteins. Nat Rev Mol Cell Biol 2013; 14: 369-81; PMID: 23657496; http://dx. doi. org/10. 1038/nrm3582.
66. Vodermaier HC. APC/C and SCF: controlling each other and the cell cycle. Curr Biol 2004; 14: R787-96; PMID: 15380093; http://dx. doi. org/10. 1016/j. cub. 2004. 09. 020.
67. Purnapatre K, Gray M, Piccirillo S, Honigberg SM. Glucose inhibits meiotic DNA replication through SCFGrr1p-dependent destruction of Ime2p kinase. Mol Cell Biol 2005; 25: 440-50; PMID: 15601864; http://dx. doi. org/10. 1128/MCB. 25. 1. 440-450. 2005.
68. Carlson M. Glucose repression in yeast. Curr Opin Microbiol 1999; 2: 202-7; PMID: 10322167; http://dx. doi. org/10. 1016/S1369-5274(99)80035-6.
69. Ozcan S, Johnston M. Three different regulatory mechanisms enable yeast hexose transporter (HXT) genes to be induced by different levels of glucose. Mol Cell Biol 1995; 15: 1564-72; PMID: 7862149.
70. Spielewoy N, Flick K, Kalashnikova TI, Walker JR, Wittenberg C. Regulation and recognition of SCFGrr1 targets in the glucose and amino acid signaling pathways. Mol Cell Biol 2004; 24: 8994-9005; PMID: 15456873; http://dx. doi. org/10. 1128/MCB. 24. 20. 8994-9005. 2004.
71. Kim J-H, Brachet V, Moriya H, Johnston M. Integration of transcriptional and posttranslational regulation in a glucose signal transduction pathway in Saccharomyces cerevisiae. Eukaryotic Cell 2006; 5: 167-73; PMID: 16400179; http://dx. doi. org/10. 1128/EC. 5. 1. 167-173. 2006.
72. Tudzarova S, Colombo SL, Stoeber K, Carcamo S, Williams GH, Moncada S. Two ubiquitin ligases, APC/C-Cdh1 and SKP1-CUL1-F (SCF)-b-TrCP, sequentially regulate glycolysis during the cell cycle. PNAS 2011; 108: 5278-83; PMID: 21402913; http://dx. doi. org/10. 1073/pnas. 1102247108.
73. Almeida A, Bolaños JP, Moncada S. E3 ubiquitin ligase APC/C-Cdh1 accounts for the Warburg effect by linking glycolysis to cell proliferation. PNAS 2010; 107: 738-41; PMID: 20080744; http://dx. doi. org/10. 1073/pnas. 0913668107.
74. Colombo SL, Palacios-Callender M, Frakich N, De Leon J, Schmitt CA, Boorn L, Davis N, Moncada S. Anaphase-promoting complex/cyclosome-Cdh1 coordinates glycolysis and glutaminolysis with transition to S phase in human T lymphocytes. PNAS 2010; 107: 18868-73; PMID: 20921411; http://dx. doi. org/10. 1073/pnas. 1012362107.
75. Colombo SL, Palacios-Callender M, Frakich N, Carcamo S, Kovacs I, Tudzarova S, Moncada S. Molecular basis for the differential use of glucose and glutamine in cell proliferation as revealed by synchronized HeLa cells. PNAS 2011; 108: 21069-74; PMID: 22106309; http://dx. doi. org/10. 1073/pnas. 1117500108.
76. Sun J, Karoulia Z, Wong EYM, Ahmed M, Itoh K, Xu P-X. The phosphatase-transcription activator EYA1 is targeted by anaphase-promoting complex/Cdh1 for degradation at M-to-G1 transition. Mol Cell Biol 2013; 33: 927-36; PMID: 23263983; http://dx. doi. org/10. 1128/MCB. 01516-12.
77. Xu PX, Adams J, Peters H, Brown MC, Heaney S, Maas R. Eya1-deficient mice lack ears and kidneys and show abnormal apoptosis of organ primordia. Nat Genet 1999; 23: 113-7; PMID: 10471511; http://dx. doi. org/10. 1038/12722.
78. Zou D, Silvius D, Fritzsch B, Xu P-X. Eya1 and Six1 are essential for early steps of sensory neurogenesis in mammalian cranial placodes. Development 2004; 131: 5561-72; PMID: 15496442; http://dx. doi. org/10. 1242/dev. 01437.
79. Zou D, Silvius D, Rodrigo-Blomqvist S, Enerbäck S, Xu P-X. Eya1 regulates the growth of otic epithelium and interacts with Pax2 during the development of all sensory areas in the inner ear. Dev Biol 2006; 298: 430-41; PMID: 16916509; http://dx. doi. org/10. 1016/j. ydbio. 2006. 06. 049.
80. Zhang L, Yang N, Huang J, Buckanovich RJ, Liang S, Barchetti A, Vezzani C, O'Brien-Jenkins A, Wang J, Ward MR, et al. Transcriptional coactivator Drosophila eyes absent homologue 2 is up-regulated in epithelial ovarian cancer and promotes tumor growth. Cancer Res 2005; 65: 925-32; PMID: 15705892.
81. Pandey RN, Rani R, Yeo E-J, Spencer M, Hu S, Lang RA, Hegde RS. The Eyes Absent phosphatase-transactivator proteins promote proliferation, transformation, migration, and invasion of tumor cells. Oncogene 2010; 29: 3715-22; PMID: 20418914; http://dx. doi. org/10. 1038/onc. 2010. 122.
82. Li C-M, Guo M, Borczuk A, Powell CA, Wei M, Thaker HM, Friedman R, Klein U, Tycko B. Gene expression in Wilms' tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition. Am J Pathol. 2002; 160: 2181-90; PMID: 12057921; http://dx. doi. org/10. 1016/S0002-9440(10)61166-2.
83. Miller SJ, Lan ZD, Hardiman A, Wu J, Kordich JJ, Patmore DM, Hegde RS, Cripe TP, Cancelas JA, Collins MH, et al. Inhibition of Eyes Absent Homolog 4 expression induces malignant peripheral nerve sheath tumor necrosis. Oncogene 2010; 29: 368-79; PMID: 19901965; http://dx. doi. org/10. 1038/onc. 2009. 360.
84. Grifone R, Laclef C, Spitz F, Lopez S, Demignon J, Guidotti J-E, Kawakami K, Xu P-X, Kelly R, Petrof BJ, et al. Six1 and Eya1 expression can reprogram adult muscle from the slow-twitch phenotype into the fast-twitch phenotype. Mol Cell Biol 2004; 24: 6253-67; PMID: 15226428; http://dx. doi. org/10. 1128/MCB. 24. 14. 6253-6267. 2004.
85. Cassago A, Ferreira APS, Ferreira IM, Fornezari C, Gomes ERM, Greene KS, Pereira HM, Garratt RC, Dias SMG, Ambrosio ALB. Mitochondrial localization and structure-based phosphate activation mechanism of Glutaminase C with implications for cancer metabolism. PNAS 2012; 109: 1092-7; PMID: 22228304; http://dx. doi. org/10. 1073/pnas. 1112495109.
86. Vousden KH, Prives C. Blinded by the Light: The Growing Complexity of p53. Cell 2009; 137: 413-31; PMID: 19410540; http://dx. doi. org/10. 1016/j. cell. 2009. 04. 037.
87. Schwartzenberg-Bar-Yoseph F, Armoni M, Karnieli E. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res 2004; 64: 2627-33; PMID: 15059920; http://dx. doi. org/10. 1158/0008-5472. CAN-03-0846.
88. Kondoh H, Lleonart ME, Gil J, Wang J, Degan P, Peters G, Martinez D, Carnero A, Beach D. Glycolytic enzymes can modulate cellular life span. Cancer Res 2005; 65: 177-85; PMID: 15665293.
89. Bensaad K, Tsuruta A, Selak MA, Vidal MNC, Nakano K, Bartrons R, Gottlieb E, Vousden KH. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 2006; 126: 107-20; PMID: 16839880; http://dx. doi. org/10. 1016/j. cell. 2006. 05. 036.
90. Boidot R, Vegran F, Meulle A, Le Breton A, Dessy C, Sonveaux P, Lizard-Nacol S, Feron O. Regulation of monocarboxylate transporter MCT1 expression by p53 mediates inward and outward lactate fluxes in tumors. Cancer Res 2012; 72: 939-48; PMID: 22184616; http://dx. doi. org/10. 1158/0008-5472. CAN-11-2474.
91. Jiang P, Du W, Wang X, Mancuso A, Gao X, Wu M, Yang X. p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. Nat Cell Biol 2011; 13: 310-6; PMID: 21336310; http://dx. doi. org/10. 1038/ncb2172.
92. Aird KM, Zhang G, Li H, Tu Z, Bitler BG, Garipov A, Wu H, Wei Z, Wagner SN, Herlyn M, et al. Suppression of nucleotide metabolism underlies the establishment and maintenance of oncogene-induced senescence. CellReports 2013; 3: 1252-65.
93. Kulawiec M, Ayyasamy V, Singh KK. p53 regulates mtDNA copy number and mitocheckpoint pathway. J Carcinog 2009; 8: 8; PMID: 19439913; http://dx. doi. org/10. 4103/1477-3163. 50893.
94. Matoba S, Kang J-G, Patino WD, Wragg A, Boehm M, Gavrilova O, Hurley PJ, Bunz F, Hwang PM. p53 regulates mitochondrial respiration. Science 2006; 312: 1650-3; PMID: 16728594; http://dx. doi. org/10. 1126/science. 1126863.
95. Okamura S, Ng CC, Koyama K, Takei Y, Arakawa H, Monden M, Nakamura Y. Identification of seven genes regulated by wild-type p53 in a colon cancer cell line carrying a well-controlled wild-type p53 expression system. Oncol Res 1999; 11: 281-5; PMID: 10691030.
96. Contractor T, Harris CR. p53 negatively regulates transcription of the pyruvate dehydrogenase kinase Pdk2. Cancer Res 2012; 72: 560-7; PMID: 22123926; http://dx. doi. org/10. 1158/0008-5472. CAN-11-1215.
97. Jiang P, Du W, Mancuso A, Wellen KE, Yang X. Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence. Nature 2013; 493: 689-93; PMID: 23334421; http://dx. doi. org/10. 1038/nature11776.
98. Hu W, Zhang C, Wu R, Sun Y, Levine A, Feng Z. Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. PNAS 2010; 107: 7455-60; PMID: 20378837; http://dx. doi. org/10. 1073/pnas. 1001006107.
99. Maddocks ODK, Berkers CR, Mason SM, Zheng L, Blyth K, Gottlieb E, Vousden KH. Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. Nature 2013; 493: 542-6; PMID: 23242140; http://dx. doi. org/10. 1038/nature11743.
100. Yahagi N, Shimano H, Matsuzaka T, Najima Y, Sekiya M, Nakagawa Y, Ide T, Tomita S, Okazaki H, Tamura Y, et al. p53 Activation in adipocytes of obese mice. J Biol Chem 2003; 278: 25395-400; PMID: 12734185; http://dx. doi. org/10. 1074/jbc. M302364200.
101. Faubert B, Berger SL, Jones RG, Thompson CB, Mak TW. Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress. Genes Dev 2011; 25: 1041-51; PMID: 21576264; http://dx. doi. org/10. 1101/gad. 1987211.
102. Ide T, Brown-Endres L, Chu K, Ongusaha PP, Ohtsuka T, El-Deiry WS, Aaronson SA, Lee SW. GAMT, a p53-inducible modulator of apoptosis, is critical for the adaptive response to nutrient stress. Mol Cell 2009; 36: 379-92; PMID: 19917247; http://dx. doi. org/10. 1016/j. molcel. 2009. 09. 031.
103. Velletri T, Romeo F, Tucci P, Peschiaroli A, Annicchiarico-Petruzzelli M, Niklison-Chirou MV, Amelio I, Knight RA, Mak TW, Melino G, et al. GLS2 is transcriptionally regulated by p73 and contributes to neuronal differentiation. cc 2013; 12: 3564-73; http://dx. doi. org/10. 4161/cc. 26771.
104. Giacobbe A, Bongiorno-Borbone L, Bernassola F, Terrinoni A, Markert EK, Levine AJ, Feng Z, Agostini M, Zolla L, AgrR AF, et al. p63 regulates glutaminase 2 expression. cc 2013; 12: 1395-405; http://dx. doi. org/10. 4161/cc. 24478.
105. Rufini A, Niklison-Chirou MV, Inoue S, Tomasini R, Harris IS, Marino A, Federici M, Dinsdale D, Knight RA, Melino G, et al. TAp73 depletion accelerates aging through metabolic dysregulation. Genes Dev 2012; 26: 2009-14; PMID: 22987635; http://dx. doi. org/10. 1101/gad. 197640. 112.
106. Du W, Jiang P, Mancuso A, Stonestrom A, Brewer MD, Minn AJ, Mak TW, Wu M, Yang X. TAp73 enhances the pentose phosphate pathway and supports cell proliferation. Nat Cell Biol 2013; 15: 991-1000; PMID: 23811687; http://dx. doi. org/10. 1038/ncb2789.
107. Amelio I, Markert EK, Rufini A, Antonov AV, Sayan BS, Tucci P, Agostini M, Mineo TC, Levine AJ, Melino G. p73 regulates serine biosynthesis in cancer. Oncogene 2014; 33(42): 5039-46; PMID: 24186203.
108. Su X, Gi YJ, Chakravarti D, Chan IL, Zhang A, Xia X, Tsai KY, Flores ER. TAp63 is a master transcriptional regulator of lipid and glucose metabolism. Cell Metab 2012; 16: 511-25; PMID: 23040072; http://dx. doi. org/10. 1016/j. cmet. 2012. 09. 006.
109. Sabbisetti V, Di Napoli A, Seeley A, Amato AM, O'Regan E, Ghebremichael M, Loda M, Signoretti S. p63 promotes cell survival through fatty acid synthase. PLoS ONE 2009; 4: e5877; PMID: 19517019; http://dx. doi. org/10. 1371/journal. pone. 0005877.
110. Pardee AB. A restriction point for control of normal animal cell proliferation. Proc Natl Acad Sci USA 1974; 71: 1286-90; PMID: 4524638; http://dx. doi. org/10. 1073/pnas. 71. 4. 1286.
111. Yalcin A, Clem BF, Simmons A, Lane A, Nelson K, Clem AL, Brock E, Siow D, Wattenberg B, Telang S, et al. Nuclear targeting of 6-phosphofructo-2-kinase (PFKFB3) increases proliferation via cyclin-dependent kinases. J Biol Chem 2009; 284: 24223-32; PMID: 19473963; http://dx. doi. org/10. 1074/jbc. M109. 016816.
112. Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL, Cantley LC. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008; 452: 230-3; PMID: 18337823; http://dx. doi. org/10. 1038/nature06734.
113. Yang W, Xia Y, Ji H, Zheng Y, Liang J, Huang W, Gao X, Aldape K, Lu Z. Nuclear PKM2 regulates b-catenin transactivation upon EGFR activation. Nature 2011; 480: 118-22; PMID: 22056988; http://dx. doi. org/10. 1038/nature10598.
114. Yang W, Zheng Y, Xia Y, Ji H, Chen X, Guo F, Lyssiotis CA, Aldape K, Cantley LC, Lu Z. ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect. Nat Cell Biol 2012; 14: 1295-304; PMID: 23178880; http://dx. doi. org/10. 1038/ncb2629.
115. Yang W, Xia Y, Hawke D, Li X, Liang J, Xing D, Aldape K, Hunter T, Alfred Yung WK, Lu Z. PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis. Cell 2012; 150: 685-96; PMID: 22901803; http://dx. doi. org/10. 1016/j. cell. 2012. 07. 018.
116. Jiang Y, Li X, Yang W, Hawke DH, Zheng Y, Xia Y, Aldape K, Wei C, Guo F, Chen Y, et al. PKM2 regulates chromosome segregation and mitosis progression of tumor cells. Mol Cell 2014; 53: 75-87; PMID: 24316223; http://dx. doi. org/10. 1016/j. molcel. 2013. 11. 001.
117. Wellen KE, Hatzivassiliou G, Sachdeva UM, Bui TV, Cross JR, Thompson CB. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 2009; 324: 1076-80; PMID: 19461003; http://dx. doi. org/10. 1126/science. 1164097.
118. Galdieri L, Vancura A. Acetyl-CoA carboxylase regulates global histone acetylation. J Biol Chem 2012; 287: 23865-76; PMID: 22580297; http://dx. doi. org/10. 1074/jbc. M112. 380519.
119. Li B, Carey M, Workman JL. The role of chromatin during transcription. Cell 2007; 128: 707-19; PMID: 17320508; http://dx. doi. org/10. 1016/j. cell. 2007. 01. 015.
120. Berger SL. The complex language of chromatin regulation during transcription. Nature 2007; 447: 407-12; PMID: 17522673; http://dx. doi. org/10. 1038/nature05915.
121. Love DC, Hanover JA. The hexosamine signaling pathway: deciphering the "O-GlcNAc code. " Sci STKE 2005; 2005: re13; PMID: 16317114.
122. Yang WH, Kim JE, Nam HW, Ju JW, Kim HS, Kim YS, Cho JW. Modification of p53 with O-linked Nacetylglucosamine regulates p53 activity and stability. Nat Cell Biol 2006; 8: 1074-83; PMID: 16964247; http://dx. doi. org/10. 1038/ncb1470.
123. Drougat L, Olivier-Van Stichelen S, Mortuaire M, Foulquier F, Lacoste A-S, Michalski J-C, Lefebvre T, Vercoutter-Edouart A-S. Characterization of OGlcNAc cycling and proteomic identification of differentially O-GlcNAcylated proteins during G1/S transition. Biochim Biophys Acta 2012; 1820: 1839-48; PMID: 22967762; http://dx. doi. org/10. 1016/j. bbagen. 2012. 08. 024.
124. Olivier-Van Stichelen S, Drougat L, Dehennaut V, Yazidi-Belkoura El I, Guinez C, Mir A-M, Michalski J-C, Vercoutter-Edouart A-S, Lefebvre T. Serumstimulated cell cycle entry promotes ncOGT synthesis required for cyclin D expression. Oncogenesis 2012; 1: e36; PMID: 23552487; http://dx. doi. org/10. 1038/oncsis. 2012. 36.
125. Zhang S, Roche K, Nasheuer H-P, Lowndes NF. Modification of histones by sugar b-N-acetylglucosamine (GlcNAc) occurs on multiple residues, including histone H3 serine 10, and is cell cycle-regulated. J Biol Chem 2011; 286: 37483-95; PMID: 21896475; http://dx. doi. org/10. 1074/jbc. M111. 284885.
126. Hanover JA, Krause MW, Love DC. Bittersweet memories: linking metabolism to epigenetics through O-GlcNAcylation. Nat Rev Mol Cell Biol 2012; 13: 312-21; PMID: 22522719; http://dx. doi. org/10. 1038/nrm3334.
127. Yang YR, Song M, Lee H, Jeon Y, Choi E-J, Jang H-J, Moon HY, Byun H-Y, Kim E-K, Kim DH, et al. OGlcNAcase is essential for embryonic development and maintenance of genomic stability. Aging Cell 2012; 11: 439-48; PMID: 22314054; http://dx. doi. org/10. 1111/j. 1474-9726. 2012. 00801. x.
128. Dehennaut V, Slomianny M-C, Page A, Vercoutter-Edouart A-S, Jessus C, Michalski J-C, Vilain J-P, Bodart J-F, Lefebvre T. Identification of structural and functional O-linked N-acetylglucosamine-bearing proteins in Xenopus laevis oocyte. Mol Cell Proteomics 2008; 7: 2229-45; PMID: 18617508; http://dx. doi. org/10. 1074/mcp. M700494-MCP200.
129. Dehennaut V, Hanoulle X, Bodart J-F, Vilain J-P, Michalski J-C, Landrieu I, Lippens G, Lefebvre T. Microinjection of recombinant O-GlcNAc transferase potentiates Xenopus oocytes M-phase entry. Biochem Biophys Res Commun 2008; 369: 539-46; PMID: 18298951; http://dx. doi. org/10. 1016/j. bbrc. 2008. 02. 063.
130. Dehennaut V, Lefebvre T, Leroy Y, Vilain J-P, Michalski J-C, Bodart J-F. Survey of O-GlcNAc level variations in Xenopus laevis from oogenesis to early development. Glycoconj J 2009; 26: 301-11; PMID: 18633701; http://dx. doi. org/10. 1007/s10719-008-9166-0.
131. Hardie DG. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol 2007; 8: 774-85; PMID: 17712357; http://dx. doi. org/10. 1038/nrm2249.
132. Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol 2012; 13: 251-62; PMID: 22436748; http://dx. doi. org/10. 1038/nrm3311.
133. Imamura K, Ogura T, Kishimoto A, Kaminishi M, Esumi H. Cell cycle regulation via p53 phosphorylation by a 50-AMP activated protein kinase activator, 5-aminoimidazole-4-carboxamide-1-b-D-ribofuranoside, in a human hepatocellular carcinoma cell line. Biochem Biophys Res Commun 2001; 287: 562-7; PMID: 11554766; http://dx. doi. org/10. 1006/bbrc. 2001. 5627.
134. Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, Xu Y, Birnbaum MJ, Thompson CB. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell 2005; 18: 283-93; PMID: 15866171; http://dx. doi. org/10. 1016/j. molcel. 2005. 03. 027.
135. Liang J, Shao SH, Xu Z-X, Hennessy B, Ding Z, Larrea M, Kondo S, Dumont DJ, Gutterman JU, Walker CL, et al. The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat Cell Biol 2007; 9: 218-24; PMID: 17237771; http://dx. doi. org/10. 1038/ncb1537.
136. Poteet E, Choudhury GR, Winters A, Li W, Ryou MG, Liu R, Tang L, Ghorpade A, Wen Y, Yuan F, et al. Reversing the Warburg effect as a treatment for glioblastoma. J Biol Chem 2013; 288: 9153-64; PMID: 23408428; http://dx. doi. org/10. 1074/jbc. M112. 440354.
137. Mandal S, Freije WA, Guptan P, Banerjee U. Metabolic control of G1-S transition: cyclin E degradation by p53-induced activation of the ubiquitin-proteasome system. J Cell Biol 2010; 188: 473-9; PMID: 20176921; http://dx. doi. org/10. 1083/jcb. 200912024.
138. Owusu-Ansah E, Yavari A, Mandal S, Banerjee U. Distinct mitochondrial retrograde signals control the G1-S cell cycle checkpoint. Nat Genet 2008; 40: 356-61; PMID: 18246068; http://dx. doi. org/10. 1038/ng. 2007. 50.
139. Berg JM, Tymoczko JL, Stryer L. Biochemistry. 7th ed. New York: WH Freeman & Company; 2012.
140. Imai S, Armstrong CM, Kaeberlein M, Guarente L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 2000; 403: 795-800; PMID: 10693811; http://dx. doi. org/10. 1038/35001622.
141. Dryden SC, Nahhas FA, Nowak JE, Goustin A-S, Tainsky MA. Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle. Mol Cell Biol 2003; 23: 3173-85; PMID: 12697818; http://dx. doi. org/10. 1128/MCB. 23. 9. 3173-3185. 2003.
142. Inoue T, Hiratsuka M, Osaki M, Yamada H, Kishimoto I, Yamaguchi S, Nakano S, Katoh M, Ito H, Oshimura M. SIRT2, a tubulin deacetylase, acts to block the entry to chromosome condensation in response to mitotic stress. Oncogene 2007; 26: 945-57; PMID: 16909107; http://dx. doi. org/10. 1038/sj. onc. 1209857.
143. Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK, Guarente L, Weinberg RA. hSIR2 (SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 2001; 107: 149-59; PMID: 11672523; http://dx. doi. org/10. 1016/S0092-8674(01)00527-X.
144. Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, Guarente L, Gu W. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 2001; 107: 137-48; PMID: 11672522; http://dx. doi. org/10. 1016/S0092-8674(01)00524-4.
145. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004; 303: 2011-5; PMID: 14976264; http://dx. doi. org/10. 1126/science. 1094637.
146. Nakahata Y, Kaluzova M, Grimaldi B, Sahar S, Hirayama J, Chen D, Guarente LP, Sassone-Corsi P. The NADC-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell 2008; 134: 329-40; PMID: 18662547; http://dx. doi. org/10. 1016/j. cell. 2008. 07. 002.
147. Asher G, Gatfield D, StratmannM, Reinke H, Dibner C, Kreppel F, Mostoslavsky R, Alt FW, Schibler U. SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell 2008; 134: 317-28; PMID: 18662546; http://dx. doi. org/10. 1016/j. cell. 2008. 06. 050.
148. Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H. Control mechanism of the circadian clock for timing of cell division in vivo. Science 2003; 302: 255-9; PMID: 12934012; http://dx. doi. org/10. 1126/science. 1086271.
149. Fu L, Pelicano H, Liu J, Huang P, Lee C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 2002; 111: 41-50; PMID: 12372299; http://dx. doi. org/10. 1016/S0092-8674(02)00961-3.